Clinical Trials Logo

Hypoxia clinical trials

View clinical trials related to Hypoxia.

Filter by:

NCT ID: NCT03300063 Completed - Stroke, Acute Clinical Trials

Treating Sleep Apnea Induced Hypoxemia With Oxygen in Acute Stroke Patients

Start date: April 3, 2018
Phase: N/A
Study type: Interventional

We want to determine if treating acute ischemic stroke patients who have evidence of hypoxemia due to sleep apnea with low flow O2 during sleep might help improve clinical and functional outcomes.

NCT ID: NCT03290859 Completed - Hypoxemia Clinical Trials

Race-Specific Propofol Titration to Effect for Procedural Sedation

Start date: January 5, 2018
Phase:
Study type: Observational

Prospectively evaluate newly established guidelines and make clinicians aware of inter-racial difference in propofol sensitivity.

NCT ID: NCT03283072 Completed - Sensitivity Clinical Trials

Effects of Acute Intermittent Hypoxia on Sensory Function in Healthy Adults

SensoryFLO
Start date: September 18, 2017
Phase: N/A
Study type: Interventional

Exposure to acute intermittent hypoxia (AIH) can facilitate of motor output but no studies of sensory effects has been reported.

NCT ID: NCT03268590 Completed - Hyperoxia Clinical Trials

Neuroimaging During Pure Oxygen Breathing

Start date: October 2, 2017
Phase: Phase 4
Study type: Interventional

The investigators will conduct a non-randomized clinical trial to examine the effect of pure oxygen breathing on the brain. The study will compare cerebral blood flow, cortical electrical activity, and cognitive performance in 32 persons during room air (21% oxygen) breathing and pure oxygen (100% oxygen) breathing. Subjects will be used as their own controls. The investigators aim to: 1. Determine whether breathing 100% oxygen changes blood flow through the brain. The investigators will learn whether brain blood flow is increased, decreased or stays the same. 2. Determine if changes that might occur in brain blood flow are also accompanied by changes in the brain's electrical activity (EEG). 3. Learn whether changes in the speed at which the brain processes information (cognitive function) accompany changes in brain blood flow and electrical activity that may be seen.

NCT ID: NCT03262311 Completed - Cancer Clinical Trials

Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours

Start date: November 10, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to test the potential of a relatively simple serum assay that aims to identify patient subpopulations whose curative radiotherapy outcome is likely to be compromised by radiobiological tumour hypoxia (prognostic value) and who are most likely to gain (predictive value) from the addition of radiation sensitiser drugs or targeted radiotherapy dose escalation.

NCT ID: NCT03221387 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Sleep and Daytime Use of Humidified Nasal High-flow Oxygen in COPD Outpatients

Start date: September 10, 2017
Phase: N/A
Study type: Interventional

Humidified Nasal High-flow with Oxygen (HNHF-O2) therapy has been reported to have acute beneficial effects in patients with hypoxemic respiratory failure who have been hospitalized. The usefulness of this therapy in the outpatient setting is unproven. This pilot study will test the feasibility of using this therapy in the outpatient setting and its effects on sleep.

NCT ID: NCT03195959 Completed - Clinical trials for Pulmonary Hypertension

Effect of Normobaric Hypoxia and Hyperoxia in Patients With Pulmonary Hypertension

Start date: June 22, 2017
Phase:
Study type: Observational

Pulmonary Hypertension (PH) is a severe disease with a bad prognosis. However, thanks to extensive research in this field, there are more and better treatment options that allow patients to participate in recreational activities at moderate altitude or bring up the question of air-travel. Still very few is known about the effects hypoxic conditions have on PH patients. The aim of this study is to investigate the effects of hypoxia in comparison to normoxia and hyperoxia on pulmonary hemodynamics in patients with pulmonary hypertension during routine right heart catheterisation. We aim to get insight into the pathophysiology of pulmonary hemodynamics under hypoxic conditions in comparison to normoxia and hyperoxia in patients with pulmonary arterial and chronic thromboembolic pulmonary hypertension compared with control patients, that are scheduled for right heart catheterisation due to dyspnea but have no PH.

NCT ID: NCT03192865 Completed - Analgesia Clinical Trials

Diaphragmatic Paralysis in Arthroscopic Shoulder Surgery

Start date: October 1, 2014
Phase: N/A
Study type: Observational

This study aims to assess consequences and causes of hemidiaphragmatic paralysis for ambulatory arthroscopic shoulder surgery in patients with BMI ≥ 30 kg/m².

NCT ID: NCT03192488 Completed - Hypoxia, Altitude Clinical Trials

Effect of an H1 Receptor Antagonist on Exercise Performance in Hypoxia

Start date: August 31, 2017
Phase: Phase 4
Study type: Interventional

This study seeks to determine whether a simple, single intervention of Cetirizine / Zyrtec® use can improve exercise performance of active individuals when acutely exposed to altitude. For this project, healthy subjects will perform steady state and progressive work rate exercise, endurance performance time trials, and repeated sprint performance time trials in the laboratory at a simulated altitude of 3000m (9900ft) after dosing with 10 mg of Cetirizine or a placebo in a repeated measures design.

NCT ID: NCT03188588 Completed - Hypoxemia Clinical Trials

Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

ObsO2
Start date: January 2017
Phase:
Study type: Observational

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.